Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Incyte Corporation.
Real, source-linked trial activity for Incyte Corporation: 3 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 19, 2026. Source-linked, daily-refreshed.
PHASE2 1PHASE1 1PHASE3 1
Newest Incyte Corporation trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 4d ago | A Study to Evaluate INCA33890 in the Treatment of Circulating Tumor DN | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 9d ago | A Study to Assess the Mass Balance, Pharmacokinetics, and Metabolite P | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 19d ago | Phase 3 Study of INCB123667 Plus Bevacizumab Versus Bevacizumab Alone | Ph 3 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Incyte Corporation (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.